BCM
BML Capital Management’s Enliven Therapeutics ELVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,100
| Closed | -$881K | – | 29 |
|
|
2024
Q1 | $881K | Buy |
50,100
+100
| +0.2% | +$1.76K | 0.58% | 24 |
|
|
2023
Q4 | $692K | Hold |
50,000
| – | – | 0.52% | 25 |
|
|
2023
Q3 | $683K | Sell |
50,000
-24,232
| -33% | -$331K | 0.63% | 16 |
|
|
2023
Q2 | $1.52M | Sell |
74,232
-137,947
| -65% | -$2.82M | 1.36% | 16 |
|
|
2023
Q1 | $4.65M | Sell |
212,179
-2,805,595
| -93% | -$61.4M | 4.02% | 10 |
|
|
2022
Q4 | $12.3M | Buy |
+3,017,774
| New | +$12.3M | 11.79% | 2 |
|